Differences between revisions 4 and 5

Covid19

EU certificate

https://www.europarl.europa.eu/RegData/etudes/BRIE/2021/690618/EPRS_BRI(2021)690618_EN.pdf
There are currently four Covid-19 vaccines that have received conditional marketing authorisation in the EU (Pfizer-BioNTech, Moderna, AstraZeneca and Janssen);
In a January 2021 resolution, the Parliamentary Assembly of the Council of Europe emphasised that states must 'ensure that no one is discriminated against for not having been vaccinated, due to possible health risks or not wanting to be vaccinated'.
For example, it is argued that, since 'vaccination is currently not readily accessible for all, this could lead to a two-tier society, with the vaccinated enjoying unrestricted free movement while others face restrictions that render their right to free movement difficult or impossible to exercise in practice'.

-  ⇤ ← Revision 4 as of 2021-09-16 20:45:11 → 
  Size: 641
  Editor: localhost
  Comment:
+   ← Revision 5 as of 2021-09-16 20:46:33 → ⇥
  Size: 1002
  Editor: localhost
  Comment:
-Deletions are marked like this.
+Additions are marked like this.
 Line 7:
+ * For  example,  it  is  argued  that,  since  'vaccination  is  currently not  readily  accessible  for  all,  this could  lead  to  a  two-tier  society,  with  the  vaccinated  enjoying  unrestricted  free  movement  while  others  face  restrictions  that  render  their  right  to  free  movement  difficult  or  impossible  to  exercise  in  practice'.